UPDATE: Citigroup Upgrades MedNax As Firm Expects 'some stabilization in trends in 2019 with opportunities from incremental cost savings and new business expansion'; Sees Impending MedData Sale As An Attractive Opportunity To Monetize Non-Core Asset